Jaguar Health Inc $JAGX shares jumped 69.1 percent to $12.60 after the company announced its subsidiary, Napo Therapeutics, will receive preclinical services from the National Institute of Allergy and Infectious Diseases to develop lechlemer, a drug for cholera indication.